David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.95% |
| 2 | Healthcare | 11.57% |
| 3 | Consumer Discretionary | 9.23% |
| 4 | Communication Services | 8.8% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Enviri
NVRI
$609M
| $4.19M | 0.01% |
224,674
-51,346
| -19% | -$989K |
|
|
ABMD
1577
CALL
DELISTED
Abiomed Inc
ABMD
| $4.18M | 0.01% |
+22,300
| New | +$4.16M |
|
1578
Foster
FSTR
$401M
| $4.18M | 0.01% |
153,895
+5,094
| +3% | +$123K |
|
1579
PUT
Cognex
CGNX
$10.1B
| $4.17M | 0.01% |
68,200
-53,600
| -44% | -$3.41M |
|
|
EGIO
1580
DELISTED
Edgio, Inc. Common Stock
EGIO
| $4.15M | 0.01% |
23,529
+7,852
| +50% | +$1.55M |
|
|
CMA
1581
CALL
DELISTED
Comerica
CMA
| $4.15M | 0.01% |
47,800
-1,600
| -3% | -$129K |
|
1582
WEX
WEX
$6.81B
| $4.14M | 0.01% |
29,328
-25,494
| -47% | -$3.19M |
|
|
AY
1583
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $4.13M | 0.01% |
194,703
-341,566
| -64% | -$7.46M |
|
1584
CALL
Kimberly-Clark
KMB
$36.9B
| $4.13M | 0.01% |
34,200
-7,300
| -18% | -$851K |
|
|
PNK
1585
DELISTED
Pinnacle Entertainment Inc.
PNK
| $4.13M | 0.01% |
126,053
+107,368
| +575% | +$2.99M |
|
1586
Federal Signal
FSS
$7.36B
| $4.12M | 0.01% |
205,001
-72,607
| -26% | -$1.52M |
|
1587
Liquidity Services
LQDT
$1.35B
| $4.11M | 0.01% |
848,060
+5,107
| +0.6% | +$27.8K |
|
1588
CALL
MGM Resorts International
MGM
$10.9B
| $4.09M | 0.01% |
+122,400
| New | +$3.94M |
|
1589
Arch Capital
ACGL
$34.3B
| $4.08M | 0.01% |
134,865
-216,285
| -62% | -$6.92M |
|
1590
Thor Industries
THO
$4.14B
| $4.06M | 0.01% |
26,937
+7,103
| +36% | +$988K |
|
1591
CALL
Puma Biotechnology
PBYI
$481M
| $4.05M | 0.01% |
41,000
+10,600
| +35% | +$1.19M |
|
|
LM
1592
DELISTED
Legg Mason, Inc.
LM
| $4.05M | 0.01% |
96,521
+3,208
| +3% | +$126K |
|
|
TCS
1593
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $4.05M | 0.01% |
56,901
+8,162
| +17% | +$591K |
|
1594
Genesco
GCO
$374M
| $4.04M | 0.01% |
124,468
-163,961
| -57% | -$4.51M |
|
1595
News Corp Class B
NWS
$18.9B
| $4.04M | 0.01% |
243,676
+63,711
| +35% | +$972K |
|
1596
Exponent
EXPO
$3.33B
| $4.04M | 0.01% |
113,752
-10,178
| -8% | -$374K |
|
1597
CALL
NetEase
NTES
$82.5B
| $4.04M | 0.01% |
+58,500
| New | +$3.65M |
|
|
POLY
1598
DELISTED
Plantronics, Inc.
POLY
| $4.04M | 0.01% |
80,115
-40,722
| -34% | -$2M |
|
1599
Colliers International
CIGI
$5.39B
| $4.03M | 0.01% |
66,800
+13,500
| +25% | +$779K |
|
|
SRGA
1600
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $4.03M | 0.01% |
32,740
+335
| +1% | +$46K |
|
Similar funds
David Shaw's Q4 2017 Portfolio in Review
As of Q4 2017, David Shaw held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- David Shaw's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- David Shaw added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- David Shaw's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- David Shaw fully exited Tesla in Q4 2017, selling an estimated $230M.
- David Shaw's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- David Shaw opened 507 new positions and closed 394 in Q4 2017.
- David Shaw's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.